{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:12:30Z","timestamp":1772806350099,"version":"3.50.1"},"reference-count":23,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Non-tuberculous mycobacteria (NTM) and Aspergillus pulmonary co-infection occurs in patients with underlying lung disease and is rarely reported. We conducted a systematic search of NTM and Aspergillus pulmonary co-infection in PubMed, EMBASE, and Cochrane Library to identify cases published from 1977 to May 2022. We included 507 articles comprising 1538 cases (only 817 patients with partial relevant clinical data). Of these, 54.3% of patients were men, with a mean age of 57.7 years. Chronic obstructive pulmonary disease (21.1%), previous diagnosis of tuberculosis (18%), and asthma (11.1%) were the most common chronic lung diseases, and corticosteroids were used in 36.8% of patients. The most frequent symptoms were cough (68.2%), dyspnea (59.1%), and hemoptysis (34.1%). The most common radiological findings were bronchiectasis (52.3%) and cavitation (40.8%). NTM and Aspergillus were treated simultaneously in 47.3% of cases, whereas NTM-targeted therapy only was performed in 23.4% and Aspergillus only in 1.6%. The remaining 27.7% did not receive any treatment and were considered to be colonized. The global mortality rate was 43% (159\/370). There was an increased prevalence of NTM and pulmonary aspergillosis among patients with underlying chronic lung diseases, which led to severe pulmonary affection with a poor global prognosis.<\/jats:p>","DOI":"10.3390\/jcm11195619","type":"journal-article","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T01:41:58Z","timestamp":1664156518000},"page":"5619","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Non-Tuberculous Mycobacteria and Aspergillus Lung Co-Infection: Systematic Review"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-6036","authenticated-orcid":false,"given":"Marina","family":"Fayos","sequence":"first","affiliation":[{"name":"Unit of Infectious Diseases, Department of Internal Medicine, University Hospital 12 de Octubre, 28041 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Tiago","family":"Silva","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Internal Medicine, University Hospital 12 de Octubre, 28041 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-7529","authenticated-orcid":false,"given":"Francisco","family":"L\u00f3pez-Medrano","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Internal Medicine, University Hospital 12 de Octubre, 28041 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red CIBERINFEC, ISCIII, 28029 Madrid, Spain"},{"name":"Department of Medicine, School of Medicine, Universidad Complutense, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-8255","authenticated-orcid":false,"given":"Jos\u00e9 Mar\u00eda","family":"Aguado","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Department of Internal Medicine, University Hospital 12 de Octubre, 28041 Madrid, Spain"},{"name":"Instituto de Investigaci\u00f3n Hospital 12 de Octubre (Imas12), 28041 Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red CIBERINFEC, ISCIII, 28029 Madrid, Spain"},{"name":"Department of Medicine, School of Medicine, Universidad Complutense, 28040 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/CMR.00014-09","article-title":"Innate immunity to Aspergillus species","volume":"22","author":"Park","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000362674","article-title":"Chronic pulmonary aspergillosis: An update on diagnosis and treatment","volume":"88","author":"Godet","year":"2014","journal-title":"Respiration"},{"key":"ref_3","first-page":"2980","article-title":"Concomitant presence of Aspergillus species and Mycobacterium species in the respiratory tract of patients: Underestimated co-occurrence?","volume":"10","author":"Angebault","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in US Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.201002-0310OC","article-title":"Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems","volume":"182","author":"Prevots","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/thx.2005.046631","article-title":"Non- tuberculous mycobacteria in patients with bronchiectasis","volume":"60","author":"Wickremasinghe","year":"2005","journal-title":"Thorax"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/resp.12287","article-title":"Mycobacterium avium complex infection in non-cystic fibrosis bronchiectasis","volume":"19","author":"Zoumot","year":"2014","journal-title":"Respirology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/mmy\/myv093","article-title":"The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria","volume":"54","author":"Takeda","year":"2016","journal-title":"Med. Mycol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: An official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccm.2014.11.002","article-title":"Nontuberculous mycobacteria infections in immunosuppressed hosts","volume":"36","author":"Henkle","year":"2015","journal-title":"Clin. Chest Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1183\/09031936.06.00149805","article-title":"Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics","volume":"28","author":"Fowler","year":"2006","journal-title":"Eur. Respir. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.5588\/ijtld.12.0684","article-title":"Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada","volume":"17","author":"Damaraju","year":"2013","journal-title":"Int. J. Tuberc. Lung. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jiac.2018.04.002","article-title":"Risk stratification for the development of chronic pulmonary aspergillosis in patients with Mycobacterium avium complex lung disease","volume":"24","author":"Furuuchi","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Jhun, B.W., Jung, W.J., Hwang, N.Y., Park, H.Y., Jeon, K., and Kang, E.S. (2017). Risk factors for the development of chronic pulmonary aspergillosis in patients with nontuberculous mycobacterial lung disease. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188716"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1099\/13500872-140-9-2475","article-title":"Hydrocortisone-enhanced growth of Aspergillus spp.: Implications for pathogenesis","volume":"140","author":"Ng","year":"1994","journal-title":"Microbiology"},{"key":"ref_18","first-page":"R191","article-title":"Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: Risk factors, clinical presentation and outcome","volume":"9","author":"Leon","year":"2005","journal-title":"Crit. Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/clinids\/18.2.266","article-title":"Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole","volume":"18","author":"Drayton","year":"1994","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1440-1843.2006.00952.x","article-title":"Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease","volume":"11","author":"Kobashi","year":"2006","journal-title":"Respirology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/thx.49.5.521","article-title":"Pulmonary Mycobacterium malmoense and aspergillus infection: A fatal combination?","volume":"49","author":"Bollert","year":"1994","journal-title":"Thorax"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/thx.50.2.216","article-title":"Pulmonary Mycobacterium malmoense and Aspergillus infection","volume":"50","author":"Debieuvre","year":"1995","journal-title":"Thorax"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Phoompoung, P., and Chayakulkeeree, M. (2020). Chronic Pulmonary Aspergillosis Following Nontuberculous Mycobacterial Infections: An Emerging Disease. J. Fungi, 6.","DOI":"10.3390\/jof6040346"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/19\/5619\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:38:34Z","timestamp":1760143114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/19\/5619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":23,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["jcm11195619"],"URL":"https:\/\/doi.org\/10.3390\/jcm11195619","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}